Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia - Drug Trials For Money - Paid Clinical Trials

Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia

Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia
Condition:   Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Intervention:   Biological: PCV13 vaccine and any of the FDA-approved COVID-19 vaccine products (BNT162b2, mRNA-1273, or Ad26.COV2.S) based on local availability.
Sponsor:   Massachusetts General Hospital
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 18, 2021 / by / in
Comments